Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
In Mechelen, Belgium, on July 13, 2026, at 22:01 CET, Lakefront Biotherapeutics NV (listed on Euronext and NASDAQ as LKFT) revealed that Dr. Paulo Fontoura, who was appointed as the Executive Vice President and Global Head of Research & Development Pharma at Sanofi SA, has submitted his resignation from the Board of Directors.